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Bacterial infections can be aggravated by antibiotic treatment that induces SOS response and vesiculation. This leads to a
hypothesis concerning association of SOS with vesiculation. To test it, we conducted multiple analyses of outer membrane vesicles
(OMVs) produced from the Pseudomonas aeruginosa wild type in which SOS is induced by ciproﬂoxacin and from the LexA
noncleavable (lexAN) strain in which SOS is repressed. The levels of OMV proteins, lipids, and cytotoxicity increased for both the
treated strains, demonstrating vesiculation stimulation by the antibiotic treatment. However, the further increase was suppressed
in the lexAN strains, suggesting the SOS involvement. Obviously, the stimulated vesiculation is attributed by both SOS-related
and unrelated factors. OMV subproteomic analysis was performed to examine these factors, which reﬂected the OMV-mediated
cytotoxicity and the physiology of the vesiculating cells under treatment and SOS. Thus, SOS plays a role in the vesiculation
stimulation that contributes to cytotoxicity.
1.Introduction
A Gram-negative bacterium, Pseudomonas aeruginosa has
emerged as a prevalent nosocomial pathogen not only for
hospital-acquired [1] and medical device-related infections
[2, 3], but also for burn [4] and war-wound infections
[5]. For such a wide spectrum of infections, the molecular
pathogenesis is still incompletely understood. Mechanisms
underlying the wide range of infections may entail the
bacterial stress responses that help the microorganism to
ﬁt in new environments. The stress responses encompass
the production of outer membrane vesicles (OMVs) in a
process of vesiculation that occurs during all phases of
growth of Gram-negative bacteria [6, 7]. OMVs also play
a role in the pathogenesis as P. aeruginosa OMVs deliver
multiple enzymes and virulence factors into the host cells
[8]. Furthermore, bacteria produce OMVs in response to
environmental and cellular stress factors [9–11], as vesic-
ulation appears to increase survival of bacteria over stress.
Environmental stress constitutes antibiotic treatments that
have been found to aﬀect vesiculation. Treatment of Shigella
dysenteriae with mitomycin C, which activates the SOS
response [12, 13], led to the increased level of Shiga toxin-
associated OMV production [14] and toxin production [15].
Such stress-induced vesiculation seems to enhance survival,
since the under-vesiculating mutants of Escherichia coli
succumbed, whereas the overvesiculating mutants appeared
more viable, when they were challenged with lethal envelope2 The Scientiﬁc World Journal
stressors [16]. With vesiculation identiﬁed as a bacterial
stress response to environmental stimuli such as antibiotics,
antibacterial treatment may aggravate the infections. There-
fore, while mechanisms underlying vesiculation resulting
from stress responses, especially the antimicrobial-triggered
SOS response, remain poorly understood, it is imperative to
investigate the connection so that eﬀective intervention can
be developed.
The SOS response [17] is a transcriptional response, in
which LexA controls at least 40 SOS genes in E. coli [18–
20] and 15 in P. aeruginosa [21]. SOS is triggered when
bacteria are treated with DNA damage antibiotics, such as
the quinolone antibiotic ciproﬂoxacin used in this work.
The quinolone antibiotics target the type II topoisomerases
includingDNAgyrase(topoisomeraseII)andtopoisomerase
IV [22]. These enzymes play an essential role in controlling
superhelix density of chromosomal DNA to facilitate repli-
cation, recombination, repair, and transcription [22, 23].
Inhibiting these enzymes by ciproﬂoxacin leads to DNA
strand breaks, the SOS signals. The mechanisms of the SOS
response in P. aeruginosa and E. coli share the following
steps (Figure 1). In the absence of the SOS signals, LexA
blocks the transcription of the SOS genes [17]. When the
SOSsignalsaregeneratedduringreplicationinhibition,RecA
coproteasesensesthesignalsandbindstothesingle-stranded
DNAs to assume an active conformation [24]. Activated
RecA stimulates the autocatalytic cleavage of LexA [25].
Consequently, LexA repression of the SOS genes is dismissed
by this cleavage. Such derepression induces the SOS genes,
leading to activation of the SOS response. One of them,
sulA, is induced to inhibit and delay cell division transiently,
resulting in cell ﬁlamentation, a sign of the SOS response,
until DNA damage is ameliorated by the SOS proteins. The
SOS proteins are involved in chromosome recombination,
replication,repair,andsegregation[26,27].Ascelldivisionis
aﬀected during SOS and is involved in OMV biogenesis [28],
vesiculationmaybelinkedtoSOS.Withantimicrobialagents
inducingSOSandvesiculation,thislinkisquitelikelyasboth
SOSandvesiculationenhancebacterialsurvival[16,29].The
purpose of this study is to investigate this link with multiple
analyses.
2.MaterialsandMethods
2.1. Bacterial Strains, Media, and Chemicals. P. aeruginosa
PAO1 was obtained from the Pseudomonas Genetic Stock
Center (strain PAO0001). The LexA noncleavable (lexAN)
strain, gratefully from Dr. Floyd E. Romesberg, was con-
structed by the replacement of the catalytic serine of LexA
with alanine as described in [21] so that the SOS regulon
is repressed by lexAN in the presence of DNA damage. All
the strains were grown at 37◦C in Luria-Bertani (LB, pur-
chased from Fisher Scientiﬁc) with 1-μg/mL ciproﬂoxacin
(Sigma-Aldrich, minimal inhibitory concentrations or MIC
=0.125μg/mL)asdescribedbefore[21].Experimentsstarted
with overnight cultures derived from the one-day-old single
coloniesgrownonLBplates;experimentswithcoloniesolder
than 3 days might not be reproducible.
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Figure 1: The bacterial SOS response. The response is triggered
by DNA-damage antibiotics. This response is controlled by the
RecA-LexA interplay, in which LexA represses the SOS genes. DNA
damage activates RecA to simulate autocatalytic cleavage of LexA so
that the SOS genes are depressed and expressed. X, the mutation
rendering LexA noncleavable.
2.2. Microscopic Analysis. Microscopy and measurement of
cell length were performed as described [30, 31]. Brieﬂy, the
log-phase cells were ﬁxed as described [30] and examined
under a microscope (ZESS Axioshop 2 plus) equipped with
CCD and computerized image analysis. The cell length was
measured with NIH Image J. Signiﬁcance levels (probability
P values) in mean cell length were determined from a two-
tailed Student’s t-test.
2.3. OMV Extraction. Overnight cultures were diluted to
the OD600nm of 0.01 with 7mL LB in a 25-mL ﬂat-bottom
glass tube. The subcultures were grown in a shaker at
37◦C at the 250-rpm speed for 8hrs. After the ﬁrst two
hours, ciproﬂoxacin was added to the subcultures to the
ﬁnal concentration of 1μg/mL. OMVs were isolated by a
standard method [32] with slight modiﬁcations. The cells
in the subcultures were removed ﬁrst by centrifugation at
10,000rpm (12,000g) for 10 minutes at 4◦C and second
by ﬁltering the supernatant through a 0.2-μm ﬁlter. The
ﬁltered supernatant (6mL) was ultracentrifuged in a ﬁxed
angle rotor (Ti-1270) for 3 hours at 4◦C for 33,000rpm
(100,000g). The supernatant was discarded, and the pellet
was resuspended in 50μL of phosphate buﬀered saline (PBS)
by pipetting rather than by vortexing. The OMV samples
could be stored at 4◦C for 1 day for the macrophage assay
and 3 days for proteomic analysis without losing activity.The Scientiﬁc World Journal 3
2.4. Lipid Extraction and Quantiﬁcation. The method was
adopted from a protocol published previously [33]w i t h
slight modiﬁcations. The procedures included an extraction
of the lipids with a mixture of methanol, chloroform,
and water in a ratio of 2:2:0.8 (v/v). The OMV pellet
collected after ultracentrifugation of the 7-mL cell-free
culture was resuspended in 80μL water in an eppendorf
tube and then, to the OMV suspension, 200μL methanol,
and 200μL chloroform were added and mixed. To the cell
pellet, water was added to the ﬁnal volume of 500μL,
and the cells were resuspended completely by vigorous
vortexing. Then, an 80-μL volume of cell suspension was
transferred to an eﬀendorf tube and mixed with 200μL
methanol and 200μL chloroform. After a 10-min vortexing,
the sample was centrifuged for 10min at 13,000rpm at 4◦C.
The chloroform layer was transferred completely by gently
inserting a pipette through the water-methanol phase and
the interphase down to the bottom of the tube. To the tube
containing the aquatic phases, 100μL chloroform and 80μL
water were added and mixed by a vortexing. Centrifugation
and chloroform layer transfer were repeated as above. The
two fractions of chloroform layers were pooled; eﬀort should
be made to avoid losing any volumes of these fractions. For
quantiﬁcation, an empty eppendorf tube had been weighed,
and then, the chloroform fractions were transferred to it and
evaporated to dryness in a speed vac. The dry lipids were
weighed, and the net weight was acquired by subtracting the
tube weight.
2.5. Transmission Electron Microscope (TEM). TEM was
conducted according to a standard protocol [34]w i t h
modiﬁcations. A 10-μL volume of the OMV sample was
placed on the lacey carbon ﬁlm on 300-mesh copper grids.
The grids were incubated at 25◦C overnight. Then, they were
negatively stained by 1% uranyl acetate (w/v, Sigma) for 20
seconds,washedthreetimeswithwater,andair-dried.OMVs
were examined on an Analytical Electron Microscope (JEOL
JEM-2010F) with a Schottky ﬁeld emission electron source.
TEM was operated at accelerating voltage of 200kV, with
resolution at 0.1nm lattice with 0.19nm point-to-point,
with magniﬁcation range from 2,0000x to 1,500,000x, with
spot sizes of 2∼5nm at TEM mode, with EDS/NBD/CBD of
0.5∼2.4nm, and with specimen tilt at ±25 degrees (X, Y).
Images were taken with a camera length of 80∼2,000mm
and objective lens of Cs 0.5mm and Cc 1.1mm. For each
sample,5–10 imageswererecorded,andthediameterofeach
OMVwasmeasuredandcomparedforstatisticalsigniﬁcance
as above.
2.6. Macrophage Cytotoxicity and MTT Assay. The indicated
equal amount of OMVs (Figure 4) determined according to
the OMV protein assay were suspended in DMEM medium
and added into a 96-well plate which had been seeded with
murine macrophage J774 cells (2 × 105/well). The plate was
incubated at 37◦Cw i t h5 %C O 2 (v/v). The cytotoxicity was
examined in the macrophage cytotoxicity assays as described
previously [35] with modiﬁcations. The seeded macrophage
was incubated with OMVs at the indicated concentrations.
First,macrophagemorphologywasexaminedunderaphase-
contrast microscope with a 40-x lens [VZEISS AXIOVERT-
200 with AXIOCAM camera equipped with CCD and
computerized image analysis] after 0.5, 1, 2, 4, and 24h.
Approximately 10 ﬁelds were examined for each of duplicate
wells. Second, the commercial kit (cyto 96 nonradioactive
cytotoxicity kits from Promega) was used to measure OMV
cytotoxicity to macrophage. The concept of this kit is to
measure a stable cytosolic enzyme lactate dehydrogenase
(LDH), which is released when macrophage cells are lysed.
The released LDH then reacts with NAD, and protons are
donatedtoNADfromLDH.ThereducingNADHthenreacts
with MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide] and formazan (red) forms. By measuring
the optical density of formazan at the wavelength of 490-nm,
the cytotoxicity was quantiﬁed. The cytotoxicity is deﬁned
as the percentage of OMV-inﬂicted LDH release in contrast
to the sum of detergent-lysed maximal release (positive
control) and spontaneous release (negative control). The
assay was carried out by following the manufacturer’s
protocol. The experiment wells were assembled to contain
the 20-μL OMV sample, the 80-μLm e d i u m( D M E Mp l u s
10% FBS, v/v and the 2 × 105target cells J774 cells), and the
OMV eﬀectors. The following control wells were arranged.
The wells for eﬀecter spontaneous LDH release contained
medium and OMVs. The wells for target cell spontaneous
LDH release included only target cells (macrophage) and
medium. The wells for target cell maximum LDH release
carried medium, target cells, and the Lysis Solution. A 10-μL
volume of the Lysis Solution (10x) per 100μLo fc u l t u r e
medium was added, and the mixture was incubated for 45
minutes before the supernatant was harvested. The wells
for volume correction control contained only medium and
lysis solution. The wells for culture medium background
were used to correct phenol red and LDH activity that
might be present in serum-containing culture medium. The
96-well plate then was incubated at 37◦Cw i t h5 %C O 2
(v/v) for 4 hours. After incubation, the supernatant (40–
50μL) from each well (except for the Maximal LDH release
control) was transferred into a well in a new 96-well plate
and mixed with the same volume of substrate (tetrazolium
salt, light-sensitive, so operate in dark). The 96-wells plate
was incubated in the dark for 30 minutes at the room
temperatures, and the reaction was terminated by adding the
stop solution. The optical density was measured at the 490-
nm wavelength.
2.7. OMV Proteomic Analysis. The proteomic analysis was
performed by following a standard method [36]w i t h
slight modiﬁcations. Speciﬁcally, the OMV proteins were
fractionated by SDS-PAGE [37] (10%, w/v) and stained
by Coomassie blue. The lanes in replicates containing the
proteins were cut out, sliced into pieces (1 × 1mm), and
placed into Eppendorf tubes. The slices were subjected to
in vitro proteolysis by trypsin as follows. The ﬁrst step was
SDS removal from the gel slices. A 100-μLv o l u m eo f2 5m M
NH4HCO3/50% acetonitrile (v/v, Fisher) was added to cover
the gel slice. The mixture was vortexed for 10 minutes, and4 The Scientiﬁc World Journal
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Figure 2: Microscopy of P. aeruginosa under the ciproﬂoxacininduced SOS response. The wild-type (PAO1) and the LexA noncleavable
(lexAN) strains were grown in LB with shaking for 2hrs, and then ciproﬂoxacin (CPX) was added (1μg/mL). The culture continued for
6hrs. (a) PAO1 without and (b) with CPX. (c) PAO1 with 5μg/mL CPX. (d) lexAN without and (e) with CPX. (f) lexAN with5μg/mL CPX.
Arrows in (c) and (f) show damaged and lysed cells. Cell bar, 5μm. Inset (b) shows transmission electron microscopy of OMVs from the
treated wild-type cultures. Inset (e) shows lexAN OMVs. OMV bar, 0.1μm.
the supernatant was discarded. These steps were repeated
until the gel became colorless. Acetonitrile (100%, v/v)
was added to cover the gel slices, and the mixtures were
incubated for a few minutes at room temperatures until
the gel slices shrank and turned white. Acetonitrile in the
gel slices was removed by spinning in a speed vacuum at
room temperatures to complete dryness. The second step
wasreduction,alkylation,andproteolysis.Forrehydrationof
the gel slices, an approximate 50-μL volume of 10-mM DTT
(Sigma) in 25-mM NH4HCO3 was added to each tube to
cover the gel slices followed by vortexing and brief spinning.
The reagents were allowed to react with gel pieces at 56◦C
for 60 minutes, and the supernatant was discarded. A 40-
μL volume of 55mM iodoacetamide (Sigma) was added
to the gel pieces, and the mixture was vortexed and then
centrifuged brieﬂy. The reaction was incubated in the dark
for 30min, and the supernatant was removed. The gels were
washed in 100μL (or enough to cover the gels) of 25-mM
NH4HCO3/50% acetonitrile (v/v) followed by vortex and
centrifugation for 5min. A 200-μL volume of acetonitrile
(100%, v/v) was added and removed as above. Trypsin
(3mg/mL, Promega) was added to just barely cover the gel
pieces, and after a brief spinning, the mixture was incubated
at 37◦C for overnight. The third was extraction of peptides
from the gel slices. The gel slices were centrifuged brieﬂy, and
the aquatic extract supernatant was collected into a 0.5-mL
Eppendorf tube. To the gel pieces, a 30-μLv o l u m eo f0 . 1 %
formic acid (v/v, Burdic & Jacson) in 25-mM NH4HCO3 was
added,followedbyvortexingfor15minandspinningbrieﬂy.
The supernatant was harvested and pooled into the aquatic
extract supernatant. The collected samples were then spun
in a speed-vacuum to reduce the volume to approximately
10μL (avoid complete dryness). The samples were stored
at −20◦C. Lastly, capillary liquid chromatography-tandem
massspectrometry(LC/MS/MS)wasconductedattheRCMI
Proteomics & Protein Biomarkers Cores to determine the
peptides derived from the proteins in the gel slices. Capillary
LC/MS/MS was performed with a linear ion trap tandem
mass spectrometer (LTQ-XLS, ThermoFisher), where the
top 7 eluting ions were fragmented by collision-induced
dissociation.
Proteins were identiﬁed by searching MS/MS spectra
against the NCBI nonredundant protein database (version
20100306; 10551781 sequences and 3596151245 residues).
A probability-based database searching algorithm (Mas-
cot, Matrixscience) was followed as described previously
[38] with modiﬁcations. Brieﬂy, database search criteria
include taxonomy, bacteria (eubacteria, 3035644 sequences);
enzyme, trypsin; variable modiﬁcations, carbamidomethyla-
tion of cysteines and oxidation of methionines; mass values,
monoisotopic; protein mass, unrestricted; peptide mass
tolerance, ±1000ppm; fragment mass tolerance, ±0.8Da;
max missed cleavages, three instrument type, ESI-TRAP;
number of queries, 87976. Peptide score distribution: Ions
score is −10log (P), where P is the probability that the
observed match is a random event.
With the molecular weight search (MOWSE) peptide-
mass database developed [39], the MOWSE scoring algo-
rithm was used to calculate a score of each peptide entry.
Brieﬂy, the experimental mass values were searched across
a calculated peptide mass database. Match of experimental
mass values with calculated values were counted when the
calculated value was in the range of a given mass tolerance
of an experimental value. These matches were probability
(P) based to ensure that the observed match is a random
event. In a search for such random matches, the signiﬁcance
threshold was set for P to be ≤0.05, that is, a 1 in 20 chance
of being a false positive. The matches were scored, basedThe Scientiﬁc World Journal 5
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Figure 3: OMV production from P. aeruginosa under the ciproﬂoxacin-induced SOS response. (a) Growth of the wild-type (PAO1)
and the LexA noncleavable strains. Both strain were grown in LB with shaking for 2hrs, and then ciproﬂoxacin (CPX) was added. The
culture continued for 6hrs. OMVs were isolated from the wild-type and the lexAN cells treated with or without ciproﬂoxacin (CPX). (b)
Quantiﬁcation of OMV proteins by Bradford (n = 7) and (c) OMV lipids by weight (n = 3). (
∗P<0.05).
on the calculated P, that is, −10log (P). The higher the
score, the lower the P value. These ions scores were used to
calculate protein score, which was the sum of the highest
ions score for each distinct sequence. The proteins that
were consistently detected in the replicates were counted.
The inferred proteins were further categorized for functions
and domains in amino acid sequences with the protein
analysis software and with the published data. Functions and
amino acid sequences were inferred by using http://www
.uniprot.org/uniprot/O67077. Proteins with signal peptide
were searched with http://www.signalpeptide.de/index.
php?m=myproteinindex. Signal peptide in the proteins was
predicted by using http://www.cbs.dtu.dk/services/SignalP/.
Transmembrane domains were deduced with http://www.ch
.embnet.org/software/TMPRED form.html.
3. Results
3.1. Vesiculation Under Ciproﬂoxacin-Triggered SOS. The
hypothesis concerning association of SOS with vesiculation
was tested. The P. aeruginosa wild-type and the LexA non-
cleavable (lexAN) strains were treated with ciproﬂoxacin
at 1μg/mL. OMVs were extracted from these strains. The
rationale for the antibiotic treatment was that this antibiotic
was known to activate the SOS response in P. aeruginosa at
1μg/mL, but SOS was noninducible in the lexAN strain [21].
Thus, testing of these strains with this drug would provide
data relevant to SOS. When treated with the antibiotic, the
wild-type cells became more ﬁlamented (cell length: 5.1μm
± 1.2 and n = 169) than the lexAN cells (4.61μm ± 1.2
and n = 89) (Figures 2(b) and 2(e), P<0.0001). The6 The Scientiﬁc World Journal
signiﬁcant cell ﬁlamentation is the manifestation of the SOS
response [30, 40–43]. It is impossible to complement the
lexAN mutant, because the lexAN phenotype is dominant;
that is, in the lexAN background, the wild-type LexA would
be cleaved, while the lexAN would remain not degraded
during SOS. Besides, when both the wild-type and the lexAN
cells were treated with ciproﬂoxacin at 1μg/mL, lysed cells
appeared imperceptible (<2%, n = 500), in contrast to
treatment at 5μg/mL (minimal bactericidal concentration,
MBC = 3.25μg/mL) that led to noticeable damaged and
lysed cells (20%–30%, Figures 2(c) and 2(f)). With the
growth conditions determined, OMVs were isolated by
ultracentrifugation from the cell-free supernatants of the
wild-type and the lexAN cultures shown in Figures 2(b) and
2(e). The presence of OMVs in the samples was conﬁrmed
with transmission electron microscopy (Figures 2(b) and
2(e) insets). The diameters of OMVs from both strains
appeared similar (P = 0.2a n dn = 70). Additionally,
phage activity was not detected in the 1-μg/mL-drug-treated
cell-free cultures and the OMV samples (data not shown).
Hence,whenthecellsgrewwiththeantibioticat1μg/mLand
producedOMVs,thelikelihoodofOMVcontaminationwith
the unrelated proteins from lysed cells appeared very small
and was further addressed as below.
3.2. Increase in OMV Protein Levels under SOS. OMVs
were quantiﬁed from the wild-type and the lexAN strains
treated with ciproﬂoxacin at 1μg/mL. Brieﬂy, both the
wild-type and LexA noncleavable strains were grown with
ciproﬂoxacin at 1μg/mL. Both strains exhibited similar
growth behaviors in the absence and in the presence of
ciproﬂoxacin (Figure 3(a)). Since OMV protein quantity
appeared to reﬂect the levels of OMVs [44], the OMV levels
weredeterminedfromthesamevolumeofculturecontaining
the equal number of cells (Figure 3(a) at 480min) by using
Bradford assay of OMV proteins. With the ciproﬂoxacin
treatment, the level of the wild-type OMV proteins increased
more than 100-fold, as compared to that without (∗P<
0.0001, Figure 3(a)). While the level of OMV proteins
from the treated lexAN strain went up versus that of the
untreated (P<0.01), it did not reach the wild-type level,
displaying 33% reduction reproducibly below the wild-type
level (∗P<0.05, Figure 3(a)). These results demonstrate that
vesiculation is stimulated by the antibiotic treatment. The
data with lexAN suggest that the stimulation is attributed by
LexA-dependent and independent mechanisms. The LexA-
dependent mechanism of OMV stimulation involves SOS.
The OMV protein level in the wild-type strain, which
increased above that of the lexAN strain, was suppressed in
the lexAN strain. Namely, the levels were increased when the
SOS repressor LexA was autocleaved in the wild-type strain
during SOS [25], but when LexA was made noncleavable
in the lexAN strain [21], further augmentation appeared
to cease. Therefore, these OMV proteins increased in the
wild type but suppressed in the lexAN strain were termed
the SOS-related. The LexA-independent mechanism may
account for the increased levels of OMV proteins from
the lexAN mutant over those from the untreated. These
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Figure 4: OMV-mediated macrophage cytotoxicity is SOS depen-
dant. OMVs isolated from the wild-type (wt) and the LexA
noncleavable (lexAN) cells as indicated were incubated with
macrophage. Top: phase-contrast microscopy of macrophage incu-
b a t e dw i t hO M V sa t1 . 3μg/mL after a 1hr incubation. Bar, 20μm.
Bottom:cytotoxicitywasmeasuredasthelevelsofreleasedcytosolic
lactate dehydrogenase after 4hr incubation. It was set 0 for the
macrophage-only control. OMV concentrations: grey, 1.3μg/mL;
doted, 0.65μg / m L ;b l a n k ,0 . 3 2 5μg/mL. (∗P<0.05, n = 4).
proteins were accordingly termed the SOS independent.
Yet, the level was lower than that of the SOS-induced wild
type (Figure 3(a)). In conclusion, the OMV protein level is
increased from the cells treated with the antibiotic, and SOS
contributes to the additional augmentation.
3.3. Increase in OMV Lipid Levels under SOS. It seemed
possible that the proteins unrelated to OMVs but produced
during SOS might be co-centrifuged with OMVs. This
possibility was excluded by OMV lipid quantiﬁcation. From
OMV protein quantiﬁcation, given the observation that the
increase in the OMV protein level in the treated wild-
type strain was suppressed in the treated lexAN strain
(Figure 3(a)), we wanted to conﬁrm the increase in vesic-
ulation with the lipid assay. The lipids were extracted from
OMVs and cells, and the total dry lipids were weighed as
described previously [33]. The OMV lipids of the wild-type
strain treated with ciproﬂoxacin were heavier than those
of the lexAN strain (∗P<0.05, Figure 3(b)). In contrast,
the weights of the total lipids from cells did not change
signiﬁcantly, irrespective of strains and treatment (P ≥ 0.1,
data not shown). Thus, the OMV lipid mass increased for
the treated wild type, and the augmentation was suppressed
in the treated lexAN strain, the results consistent with the
OMV protein quantiﬁcation. This consistency ruled out the
possibility of OMV contamination with unrelated proteins
butsupportedthenotionofSOSinvolvementinvesiculation,
yet, the SOS-unrelated factors contributing to the increase
cannot be excluded.
3.4. OMV-Mediated Macrophage Cytotoxicity under SOS.
Since OMVs act as a virulence factor [8, 45] and the OMV
levelsincreaseduringtheantibiotic-induced SOS,wewantedThe Scientiﬁc World Journal 7
Table 1: The WT OMV proteins.
Protein access ID Protein description Score pI Mass Predicted functions Membrane
domains
(1) gi|15595792 OstA precursor [P. aeruginosa
PAO1] 366 5.41 104207 Organic solvent tolerance protein SP, TM
(2) gi|30525581 ChaPs, heat-shock protein
[Piscirickettsia salmonis] 174 4.79 57310 Protein folding, immunogenic
protein n, TM
(3) gi|15595608 PilJ [P. aeruginosa PAO1] 165 4.65 72484 Cell motility, twitching motility SP, TM
(4) gi|15597641 Glycine dehydrogenase
[P. aeruginosa PAO1] 133 5.68 103853 Degradation of glycine n, TM
(5) gi|254236694 OprC precursor, putative
[P. aeruginosa C3719] 117 6.02 79268 Copper transport outer
membrane porin SP, TM
(6) gi|15599015 SecF [P. aeruginosa PAO1] 115 4.81 33021 Protein translocation SP, TM
(7) gi|15599417
Fe(III)-pyochelin OM
receptor precursor
[P. aeruginosa PAO1]
107 5.86 79943
Siderophore-iron
transmembrane transporter
activity
SP, TM
(8) gi|309885 Aspartate transcarbamoylase
[P. aeruginosa PAO1] 102 6.17 36521 Pyrimidine biosynthesis n, n
(9) gi|83718562
Peptide synthetase-like
protein [Burkholderia
thailandensis E264]
96 5.91 349402 Peptide synthesis n, TM
(10) gi|152986344 YaeT [P. aeruginosa PA7] 94 5.02 88222 OMP assembly complex SP, TM
(11) gi|124022818
Phosphate binding protein
[Prochlorococcus marinus str.
MIT 9303]
90 9.51 18989 ABC transport SP, TM
(12) gi|167840097
Phospholipase D
[Burkholderia thailandensis
MSMB43]
88 6 64431 Lipid catalytic activity n, TM
(13) gi|167035883 TonB-dependent copper
receptor [P. putida GB-1] 87 5.77 74399 Copper receptor SP, TM
(14) gi|28871621
Polyribonucleotide
nucleotidyltransferase
[P. syringae pv. tomato str.
DC3000]
81 5.20 74880 mRNA degradation n, TM
(15) gi|15600748 ATP synthase subunit γ
[P. aeruginosa PAO1] 73 7.70 31533 ATP production n,n
(16) gi|70732441 M48 family peptidase
[P. ﬂuorescens Pf-5] 69 7.66 28833 Protein dagradation SP, TM
(17) gi|50085971 Acridine eﬄux pump
[Acinetobacter sp. ADP1] 67 6.36 114705 Eﬄux pump n, TM
(18) gi|15596751
Cytochrome oxidase subunit
(cbb3-type) [P. aeruginosa
PAO1]
66 9.42 53073 Electron transport chain n, TM
(19) gi|119713613 SecD [uncultured marine
bacterium EB0 39H12] 62 5.63 67763 Protein translocation n, TM
(20) gi|7715581 PspA [Streptococcus
pneumoniae] 61 4.70 27305 Pneumococcal surface protein A n, n
(21) gi|10945103 PapA [P. aeruginosa] 61 4.87 71649 Lipid metabolic process SP, TM
(22) gi|121605556 Catalase [Polaromonas
naphthalenivorans CJ2] 61 6.26 54212 Hydrogen peroxide catabolic
process n, n
(23) gi|94495248 Rhizopine catabolism protein
[Sphingomonas sp. SKA58] 60 5.91 38825 Oxidation reduction n, TM
(24) gi|116328093
Zn-dependent hydrolase
[Leptospira borgpetersenii
serovar Hardjo-bovis L550]
59 5.67 30997 Hydrolase activity SP, TM
(25) gi|149378317 PAS [Marinobacter algicola
DG893] 59 5.97 57059 Signal transducer activity,
chemotaxis TM8 The Scientiﬁc World Journal
Table 1: Continued.
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(26) gi|119356290
Molybdate ABC transporter,
ATPase subunit [Chlorobium
phaeobacteroides DSM 266]
59 9.23 38876 ABC transport n, n
(27) gi|117619653 Methyl-accepting chemotaxis
transducer [P. stutzeri A1501] 59 4.67 58670 Methyl-accepting chemotaxis SP, TM
(28) gi|119899764
MCP-domain-containing
signal transduction protein
[Azoarcus sp. BH72]
59 5.80 53615 Signal transduction SP, TM
(29) gi|887858 DcrH [Desulfovibrio vulgaris
str. Hildenborough] 59 5.71 104664 Signal transduction SP, TM
(30) gi|28869218 Aerotaxis receptor [P. syringae
pv. tomato str. DC3000] 59 5.70 56965 Aerotaxis n, TM
(31) gi|112004994 Symbionin [Buchnera
aphidicola] 58 5.13 57904 Protein folding n, TM
(32) gi|15597430 PslD, bioﬁlm proteins
[P. aeruginosa PAO1] 58 8.66 27891 polysaccharide transmembrane
transport SP, TM
(33) gi|154253615
Molybdenum cofactor
biosynthesis protein C
[Parvibaculum
lavamentivorans DS-1]
58 9.64 16871 Cofactor biosynthesis n, n
(34) gi|15600235 PilO [P. aeruginosa PAO1] 57 5.04 22805 Cell motility, type 4 ﬁmbrial
biogenesis n, TM
(35) gi|29830660 Oxidoreductase [Streptomyces
avermitilis MA-4680] 57 5.01 33162 Electron transport chain n, TM
(36) gi|108803685
Bifunctional homocysteine
S-methyltransferase
[Rubrobacter xylanophilus
DSM 9941]
57 6.33 65183 Amino-acid biosynthesis n, TM
(37) gi|15595488 OprE precursor [P. aeruginosa
PAO1] 54 8.67 49637 Anaerobically-induced OM
porin SP, TM
(38) gi|121997032
Glycolate oxidase iron-sulfur
subunit [Halorhodospira
halophila SL1]
53 8.55 43945 Oxidation reduction n, n
(39) gi|161508096
Biotin-acetyl-CoA-
carboxylase ligase
[Lactobacillus helveticus DPC
4571]
53 9 37120 Protein modiﬁcation process n, n
(40) gi|119773234 GTPase EngB [Shewanella
amazonensis SB2B] 52 6.97 24168 Cell division n, n
(41) gi|75764772
FtsK [Bacillus thuringiensis
serovar israelensis ATCC
35646]
50 4.33 40378 Cell division SP, TM
(42) gi|3237312 FimV [P. aeruginosa PAO1] 50 4.33 98113 Cell motility, twitching motility SP, TM
(43) gi|145588417
Ferric uptake regulator family
protein [Polynucleobacter
necessarius subsp.
asymbioticus
QLW-P1DMWA-1]
50 6.29 17176 Repressor of the iron transport
operon n, n
(44) gi|163846285
Deoxyribose-phosphate
aldolase [Chloroﬂexus
aurantiacus J-10-ﬂ]
50 6.08 27440 Deoxyribonucleotide catabolic
process n, n
(45) gi|107099581 Hypothetical+C448 01000594
[P. aeruginosa PACS2] 267 5.13 101779 Unknown Unknown
(46) gi|15598924 Hypothetical PA3729 [P.
aeruginosa PAO1] 249 5.18 75836 Unknown n, TM
(47) gi|15599685 Hypothetical PA4489 [P.
aeruginosa PAO1] 179 5.48 167326 Putative endopeptidase inhibitor
activity SP, TM
(48) gi|156932378
Hypothetical ESA 00154
[Enterobacter sakazakii ATCC
BAA-894]
167 4.83 57278 Protein folding n, TMThe Scientiﬁc World Journal 9
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(49) gi|15596261 Hypothetical PA1064
[P. aeruginosa PAO1] 116 5.38 24157 Unknown n, TM
(50) gi|218890269 Hypothetical PLES 15291
[P. aeruginosa LESB58] 97 6.34 28636 Unknown SP, TM
(51) gi|15595825 Hypothetical PA0628
[P. aeruginosa PAO1] 92 8.80 35848 Unknown n, n
(52) gi|15600425 Hypothetical PA5232
[P. aeruginosa PAO1] 90 9.11 38586 Protein transporter SP, TM
(53) gi|15596143 Hypothetical PA0946
[P. aeruginosa PAO1] 86 4.93 36754 Unknown SP, TM
(54) gi|107103341
Hypothetical
PaerPA 01004410
[P. aeruginosa PACS2]
84 9.02 67631 Unknown Unknown
(55) gi|15599691 Hypothetical PA4495
[P. aeruginosa PAO1] 84 5.79 24864 Unknown SP, TM
(56) gi|15600607 Hypothetical PA5414
[P. aeruginosa PAO1] 75 5.76 22533 Unknown SP, TM
(57) gi|1162960
Protein homologous to
HI0366 in Haemophilus
inﬂuenzae [P. aeruginosa
PAO1]
72 6.77 22403 Unknown SP, TM
(58) gi|148980343
Hypothetical VSWAT3 23674
[Vibrionales bacterium
SWAT-3]
59 4.85 56161 Chemotaxis SP, TM
(59) gi|86146473 Hypothetical MED222 12698
[Vibrio sp. MED222] 59 4.76 68870 Signal transducer activity n, TM
(60) gi|32266390
Hypothetical HH0891
[Helicobacter hepaticus ATCC
51449]
59 4.99 52013 Signal transducer activity n, n
(61) gi|89893845
Hypothetical DSY1099
[Desulﬁtobacterium hafniense
Y51]
59 5.00 54148 Signal transducer activity n, n
(62) gi|18309647
Hypothetical CPE0665
[Clostridium perfringens str.
13]
59 4.91 28888 Unknown Unknown
(63) gi|160938898
Hypothetical CLOBOL 03792
[Clostridium bolteae ATCC
BAA-613]
59 4.79 60828 Chemotaxis SP, TM
(64) gi|167772543
Hypothetical ANACOL 03921
[Anaerotruncus colihominis
DSM 17241]
59 4.66 71478 Signal transducer activity SP, TM
(65) gi|158334828
Hypothetical AM1 1665
[Acaryochloris marina
MBIC11017]
59 4.54 28589 Unknown n, n
(66) gi|146298741
Hypothetical Fjoh 0980
[Flavobacterium johnsoniae
UW101]
58 8.90 168226 Unknown SP, TM
(67) gi|126348240
Conserved hypothetical
[Streptomyces ambofaciens
ATCC 23877]
58 4.68 123551 Unknown Unknown
(68) gi|162454210
Hypothetical sce5933
[Sorangium cellulosum So ce
56]
56 10.06 49450 Unknown SP, TM
(69) gi|159184340
Hypothetical Atu0493
[Agrobacterium tumefaciens
str. C58]
56 8.83 17570 Unknown Unknown
(70) gi|120536835 Hypothetical Maqu 4123
[Marinobacter aquaeolei VT8] 54 6.02 36805 Unknown n, n
(71) gi|88800650 Hypothetical MED297 05259
[Reinekea sp. MED297] 53 5.05 74044 Unknown Unknown10 The Scientiﬁc World Journal
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(72) gi|107103648
Hypothetical
PaerPA 01004718
[P. aeruginosa PACS2]
52 8.92 52714 Unknown Unknown
(73) gi|124385398
Hypothetical
BMA10229 A0995
[Burkholderia mallei NCTC
10229]
52 5.66 5192 Unknown n, n
(74) gi|94986987
Hypothetical LI0545
[Lawsonia intracellularis
PHE/MN1-00]
51 6.43 11768 Unknown n, n
TM: transmembrane domains; SP: signal peptide; pI: isoelectric point.
to investigate whether OMVs from the SOS strains diﬀeren-
tially aggravates cytotoxicity. OMVs isolated from the wild-
type and the lexAN cultures, either treated as above with
ciproﬂoxacinorwithout,wereaddedtomacrophageinequal
amounts. The cytotoxicity was assessed as described pre-
viously [35]. First, macrophage morphology was examined
after incubation with OMVs from the untreated wild-type
bacterial cells for 0.5, 1, 2, 4, and 24h. Morphology changes
appeared in the ﬁrst h (Figure 4 Upper). OMVs from the
ciproﬂoxacin-treated wild-type and the mutant cells caused
dramatic alterations in the morphology of the macrophage,
including cell shrinkage, detachment, and lysis, when com-
pared with OMVs from the untreated bacterial cells. In
contrast, treatment of macrophage with ciproﬂoxacin at
1μg/mL did not cause the cytotoxic morphology, the result
excluding a possibility of ciproﬂoxacin-inﬂicted toxicity
presumably caused by the drug-carrying OMVs. Second, the
cytotoxicity was quantiﬁed. It is deﬁned as the percentage
of the OMV-inﬂicted LDH release from macrophage in the
detergent-lysed maximal release from macrophage (OMVs
or macrophage alone did not lead to a LDH-increase). As
shown in Figure 4 (lower), the OMV-inﬂicted macrophage
toxicity appeared concentration-dependent. Cytotoxicity by
OMVs from the treated wild-type strain increased over 55%
versus that by OMVs from the untreated (P<0.05). These
results indicate that the OMV-mediated cytotoxicity is stim-
ulated by OMVs from the antibiotic-treated bacterial cells.
However, this stimulated cytotoxicity was not observed in
OMVs from the treated lexAN culture (P<0.05). Therefore,
LexA appeared to suppress the increased cytotoxicity.
3.5. OMV Subproteomic Analysis. Under the ciproﬂoxacin
treatment, the increased levels of the OMV proteins, lipids
and the OMV-mediated cytotoxicity in the wild-type strain
appeared to be suppressed in the lexAN strain. Many
interesting questions were raised from these results as to
what OMV proteins would be LexA-suppressed and what
wouldbecytotoxicity-related.Toaddressthem,weexamined
the OMV subproteomes from the treated wild-type and the
lexAN strains. The rationale for targeting the two treated
strains was the following. For the treated wild-type strains,
the OMV protein level was increased but suppressed for the
lexAN strain. Thus, comparison of the OMV subproteomic
data obtained from the two treated strains would provide
information relevant to LexA or SOS. The comparison
could help sort out the OMV proteins: the LexA-related
and ciproﬂoxacin-speciﬁc or SOS-unrelated OMV proteins.
When bacteria are treated with a certain antibiotic, drug-
speciﬁc proteins were previously observed, such as OMPs
[46, 47] and OMV proteins [48], which are unrelated to
SOS. Most likely, the ciproﬂoxacin-speciﬁc OMV proteins
would be found in both the wild-type and the lexAN OMV
subproteomes, whereas the LexA-related OMV proteins
wouldbedetectedintheOMVsubproteomeofthewild-type
strain where LexA is autocleaved.
Experimentally, the OMV proteins from the antibiotic-
treated wild-type and lexAN strains were characterized by
the SDS-PAGE-based proteomic analysis (Figure 5). While
small diﬀerences were observed in the OMV protein proﬁles
for the treated wild-type and the lexAN strains (Figure 5),
subtle distinctions were expected, based on LexA repression
of gene expression, especially of the SOS regulons [18–21].
To unveil the diﬀerences, the in vitro trypsin proteolysis and
capillary LC/MS/MS analysis was performed to determine
the OMV proteins in the gel slices (Figure 5). The degraded
peptide masses were determined and searched across the
bacterial protein databases with the P<0.05-based MOWSE
scoring algorithm [39]. Totally, 145 proteins were identiﬁed
in the OMV subproteomes from the treated wild-type and
the lexAN strains (Tables 1–3). Many of the known OMV
proteins, such as OstA (no. 1) [49] and OprE (no. 37)
[50, 51], were detected in the wild-type OMVs (Figure 5
and Table 1), whereas GroEL (no. 75) [52]a n dO p r F( n o .
78) [50, 51] in both the wild-type and the lexAN OMVs
(Table 2). Thus, the OMV subproteomes were conﬁrmed
to harbor some known OMV proteins. Moreover, with the
SOS status of the wild-type and the lexAN strains used, the
subproteomic analyses led to discovery and categorization of
SOS- and cytotoxicity-related OMV proteins. The proteins
detected only in OMVs from the drug-treated wild-type cells
were termed the WT OMV proteins (74 proteins listed in
Table 1 or 51% of 145). Since SOS was triggered in the wild
type but repressed in the lexAN strain [21], the proteins
produced during SOS were expected to emerge in the wild-
type OMVsbut not in thelexAN OMVs. These proteins wereThe Scientiﬁc World Journal 11
Table 2: The common OMV proteins.
Protein access ID Protein description Score pI Mass Predicted functions Membrane
domains
(75) gi|576779 GroEL [P. aeruginosa] 784 5.04 57036 Protein folding n, n
(76) gi|167855908 50S ribosomal protein L28
[Haemophilus parasuis 29755] 242 4.90 57645 Protein synthesis n, n
(77) gi|15596780
Succinate dehydrogenase
ﬂavoprotein subunit [P. aeruginosa
PAO1]
175 6.04 63492 Tricarboxylic acid cycle n, TM
(78) gi|15596974 OprF precursor [P. aeruginosa
PAO1] 166 4.98 37616 Major porin, ion transport SP, TM
(79) gi|15596375 OprH precursor [P. aeruginosa
PAO1] 107 9.00 21561 Response to Mg2+ starvation SP, TM
(80) gi|15598888 OMP precursor [P. aeruginosa
PAO1] 103 9.45 28497 OM SP, TM
(81) gi|2626833 Chemotactic transducer
[P. aeruginosaPAO1] 98 4.88 68395 Chemotaxis SP, TM
(82) gi|15599262 OprG precursor [P. aeruginosa
PAO1] 93 4.85 25178 OmpW family SP, TM
(83) gi|15598278 Glycine betaine transmethylase
[P. aeruginosa PAO1] 74 4.74 71360
Utilization of choline and glycine
betaine as carbon and nitrogen
sources
SP, TM
(84) gi|15596750 Cytochrome c oxidase subunit
[P. aeruginosa PAO1] 74 7.79 22744 Electron carrier activity n. TM
(85) gi|37522034 Glycosyltransferase [Gloeobacter
violaceus PCC 7421] 70 8.96 47611 Biosynthesis of glycoproteins n, n
(86) gi|15596166 TolQ [P. aeruginosa PAO1] 67 5.96 25266 Import of group A colicins for
envelope integrity n, TM
(87) gi|15599941 SecG [P. aeruginosa PAO1] 65 5.21 13199 Protein translocation n, TM
(88) gi|151545 RNA polymerase subunit
[P. aeruginosa] 63 4.95 30372 RNA synthesis n, n
(89) gi|115523809 OmpA/MotB domain-containing
protein [RhodoP. palustris BisA53] 63 7.60 45685 Major nonspeciﬁc porin SP, TM
(90) gi|114563330 Phosphoglucomutase [Shewanella
frigidimarina NCIMB 400] 62 5.39 62288 Carbohydrate metabolic process n, n
(91) gi|15596170 OprL precursor [P. aeruginosa
PAO1] 61 5.95 17914 Peptidoglycan-associated OM
lipoprotein SP, TM
(92) gi|15598193
Na(+)-translocating
NADH-quinone reductase subunit
C[ P. aeruginosa PAO1]
61 5.67 27763
Reduction of ubiquinone-1 to
ubiquinol and transport of Na+
ions
SP, TM
(93) gi|15598107 TonB-dependent receptor, putative
[P. aeruginosa PAO1] 60 6.24 80241
High-aﬃnity binding and
energy-dependent uptake of
speciﬁc substrates into the
periplasmic space
SP, TM
(94) gi|162455126 Protein kinase [Sorangium
cellulosum So ce 56] 57 6.16 189825 Kinase activity n, n
(95) gi|15597002 Peptidyl-prolyl cis-trans isomerase
D[ P. aeruginosa PAO1] 57 4.99 68699 Protein folding n, TM
(96) gi|183602700
Site-speciﬁc
DNA-methyltransferase
[Biﬁdobacterium animalis subsp.
lactis HN019]
56 6.24 51123 DNA methylation n, n
(97) gi|15600134 HﬂC [P. aeruginosa PAO1] 50 9.48 33095 Peptidase activity SP, TM
(98) gi|15599627 Iron-sulfur protein [P. aeruginosa
PAO1] 50 6.07 20815 Iron-sulfur cluster assembly n, n12 The Scientiﬁc World Journal
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(99) gi|15595268 Hypothetica PA0070 [P. aeruginosa
PAO1] 114 8.93 31697 Unknown SP, TM
(100) gi|15596030 Hypothetica PA0833 [P. aeruginosa
PAO1] 104 8.89 24698 OmpA family SP, TM
(101) gi|15597431 Hypothetica PA2235 [P. aeruginosa
PAO1] 93 5.99 74519 Lipopolysaccharide biosynthetic
process n, TM
(102) gi|15595823 Hypothetica PA0626 [P. aeruginosa
PAO1] 87 9.67 31273 Unknown n, n
(103) gi|15599828 Hypothetica PA4632 [P. aeruginosa
PAO1] 81 6.97 29141 Proteolysis SP, TM
(104) gi|15599183 Hypothetica PA3988 [P. aeruginosa
PAO1] 67 5.23 22870 OM assembly SP, TM
(105) gi|152989513 Hypothetica PSPA7 0777
[P. aeruginosa PA7] 62 4.77 17484 Unknown n, n
(106) gi|15595830 Hypothetica PA0633 [P. aeruginosa
PAO1] 62 4.93 17528 Unknown n, n
(107) gi|15595812 Hypothetica PA0615 [P. aeruginosa
PAO1] 60 4.53 18939 Unknown n, n
(108) gi|15595813 Hypothetica PA0616 [P. aeruginosa
PAO1] 58 5.93 19410 Unknown n, TM
(109) gi|15599619 Hypothetica PA4423 [P. aeruginosa
PAO1] 51 6.69 65589 Unknown SP, TM
TM: transmembrane domains; SP: signal peptide. pI: isoelectric point.
SOS-related. However, the proteins present in OMVs from
boththetreatedwild-typeandthelexAN strainswerenamed
the common OMV proteins (35 in Table 2 or 24%). The
presence in both the OMV subproteomes implied that the
appearance in OMVs was not aﬀected by LexA; thus these
proteins were called the SOS-unrelated. The OMV proteins
present in OMVs from the lexAN cells alone were called
the lexAN OMV proteins (36 in Table 3 or 26%). While
the categorization provides insights into the antibiotic-
stimulated vesiculation, it does not seem reconciled with
the protein banding proﬁles that show slight diﬀerences in
OMV proteins from the wild-type and the lexAN strains.
The apparent discrepancy stems from the limited capacity of
SDS-PAGEinresolvingproteinswithsimilarsizesinacertain
band and inability to separate proteins of similar masses but
ofdiﬀerentpIs.Forinstance,whenparallelbandsinthewild-
typeandthelexAN OMVproteinswerecutoﬀforproteomic
analysis, the subproteomic contents of the proteins carrying
v a r i o u sp I si no n eb a n dw e r en o tc o m p l e t e l yi d e n t i c a l
to those in its counterpart (data not shown). Obviously,
the OMV subproteomic analysis appears comprehensive,
remedying the limitation of SDS-PAGE analysis.
Interestingly, the OMV subproteomes seem to reﬂect the
physiology of the cells under the antibiotic treatment and
the cytotoxicity of OMVs to host cells. For instance, the
known SOS-regulated proteins, such as FtsK (no. 41) [53]
and catalase (no. 22) [54], were detected in the OMVs from
the treated wild-type cells where SOS is induced. Proteins
of eﬄux (no. 17) and cell motility (nos. 3, 34, and 42)
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Figure 5: The SDS-PAGE based proteomic analyses of OMV
proteins from the SOS-induced and the un-induced cells. CPX,
ciproﬂoxacin. N, LexA noncleavable; and wt, wild-type. Illustrated
to the right were the proteins known to associate with OMVs,
cytotoxicity, and SOS (See text and Tables for details).The Scientiﬁc World Journal 13
Table 3: The lexAN OMV proteins.
Protein access ID Protein description Score pI Mass Predicted functions Membrane
domains
(110) gi|15599248 6,7-dimethyl-8-ribityllumazine
synthase [P. aeruginosa PAO1] 299 5.69 16403 Riboﬂavin biosynthesis n, n
(111) gi|14573303 PilA [P. aeruginosa] 160 6.23 15488 Major pilin subunit of type IV
pili n, TM
(112) gi|15598049 OprI precursor [P. aeruginosa
PAO1] 132 7.90 8829 OM lipid-anchor. SP, TM
(113) gi|15596004 AmpDh3 [P. aeruginosa PAO1] 129 5.89 28703 Peptidoglycan catabolic process n, n
(114) gi|15599856 Lipid A 3-O-deacylase
[P. aeruginosa PAO1] 116 5.87 18382 Modiﬁcation of lipid A of LPS SP, TM
(115) gi|15596159 DNA-binding stress protein
[P. aeruginosa PAO1] 100 4.96 17482 Response to stress, iron ion
homeostasis n, n
(116) gi|15599000 PilF [P. aeruginosa PAO1] 75 6.67 28520 Type 4 ﬁmbrial biogenesis SP, TM
(117) gi|15596133 LpxO2 [P. aeruginosa PAO1] 72 9.90 35737 LPS biosynthesis n, TM
(118) gi|15600371 LysM domain/BON superfamily
protein [P. aeruginosa PAO1] 69 5.45 15451 Cleavage of septal peptidoglycan
to allow cell separation n, n
(119) gi|15598026 HtpX [P. aeruginosa PAO1] 65 7.03 31573 Heat shock protein, proteolysis SP, TM
(120) gi|15600018 Mg(2+) transport ATPase, P-type 2
[P. aeruginosa PAO1] 63 5.88 99987 Magnesium-importing ATPase
activity n, TM
(121) gi|15599764 50S ribosomal protein L21
[P. aeruginosa PAO1] 62 9.85 11646 Protein synthesis n, n
(122) gi|116620118 HAD family hydrolase [Solibacter
usitatus Ellin6076] 57 5.37 22870 Phosphoglycolate phosphatase
activity n, n
(123) gi|21233204 RhlB [Xanthomonas campestris pv.
campestris str. ATCC 33913] 51 9.25 62279
ATP-dependent RNA helicase
unwinding of double stranded
RNA
n, n
(124) gi|15599463 30S ribosomal protein S7
[P. aeruginosa PAO1] 51 10.24 17493 Protein synthesis n, n
(125) gi|73537822
Twin-arginine translocation
pathway signal [Ralstonia eutropha
JMP134]
50 9.37 36128 Protein export through the
cytoplasmic membrane SP, TM
(126) gi|71064880 GltI [Psychrobacter arcticus 273-4] 50 5.11 35348 ABC glutamate/aspartate
transporter SP, n
(127) gi|15596250 HypotheticalPA1053 [P. aeruginosa
PAO1] 279 9.64 15639 Unknown SP, TM
(128) gi|15599835 HypotheticalPA4639 [P. aeruginosa
PAO1] 98 9.47 20723 Unknown SP, TM
(129) gi|15600165 HypotheticalPA4972 [P. aeruginosa
PAO1] 86 5.98 27836 Unknown SP, TM
(130) gi|15598227 HypotheticalPA3031 [P. aeruginosa
PAO1] 83 4.92 8007 Unknown SP, TM
(131) gi|15598151 HypotheticalPA2955 [P. aeruginosa
PAO1] 70 5.35 23677 Unknown SP, TM
(132) gi|145635820 HypotheticalCGSHiAA 01062
[Haemophilus inﬂuenzae PittAA] 69 5.85 56041 Unknown n, n
(133) gi|183222376
Hypothetical LEPBI I3030
[Leptospira biﬂexa serovar Patoc
strain Patoc 1 (Paris)]
61 8.40 51147 Transporter activity SP, TM
(134) gi|57233652 HypotheticalDET1586
[Dehalococcoides ethenogenes 195] 61 8.80 21290 Unknown SP, TM14 The Scientiﬁc World Journal
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(135) gi|29377408 HypotheticalEF2944 [Enterococcus
faecalis V583] 58 4.99 19312 Unknown n, n
(136) gi|15597823 HypotheticalPA2627 [P. aeruginosa
PAO1] 57 10.35 23048 Unknown n, n
(137) gi|116750341
HypotheticalSfum 2918
[Syntrophobacter fumaroxidans
MPOB]
54 5.40 89798 Carbohydrate binding SP, TM
(138) gi|167751139 Hypothetical EUBSIR 02124
[Eubacterium siraeum DSM 15702] 53 5.50 44267 Metal ion binding n, TM
(139) gi|26250264 Hypotheticalc4442 [E. coli CFT073] 53 9.39 39090 Unknown n, TM
(140) gi|167754381 Hypothetical ALIPUT 02675
[Alistipes putredinis DSM 17216] 53 6.89 18845 Methyltransferase activity n, n
(141) gi|116048834 Hypothetical PA14 52490
[P. aeruginosa UCBPP-PA14] 52 6.19 17828 Unknown n, n
(142) gi|83312716
Hypothetical amb3617
[Magnetospirillum magneticum
AMB-1]
52 5.42 89219 Cyclic nucleotide biosynthetic
process n, TM
(143) gi|154503183 Hypothetical RUMGNA 01007
[Ruminococcus gnavus ATCC 29149] 51 5.29 49010 Rhamnose metabolic process n, n
(144) gi|15598505 Hypothetical PA3309 [P. aeruginosa
PAO1] 51 5.50 16486 Response to stress n, n
(145) gi|148255416 HypotheticalBBta 4029
[Bradyrhizobium sp. BTAi1] 51 4.22 4004 Unknown n, n
TM: transmembrane domains; SP: signal peptide. pI: isoelectric point.
were also found. Since eﬄux and cell mobility are involved
in antibiotic resistance [55, 56], the presence of the related
proteins in OMVs is likely to result from a response of
the bacterial cells to the ciproﬂoxacin treatment. Further-
more, virulent proteins were detected in OMVs. In fact,
cell mobility as mentioned above is known to enhance
production of virulence factors [55]. An example in the WT
OMV proteins is M48 family peptidase (no. 16 in Table 1)
that contains Pseudomonas metalloproteases, elastase, and
alkaline protease. These proteins are believed to mediate
tissue penetration [57–59]. The examples in the common
category include cytochrome c (no. 84 in Table 2)c y t o t o x i c
to macrophage [60], and OprG (no. 82) contributing to
cytotoxicity toward human bronchial epithelial cells [61].
ExamplesinthelexAN grouparethefollowing:ATP-utilizing
enzymes such as ATPase (no. 120 of Table 3)c y t o t o x i ct o
macrophage[60]andtheLysMdomaincarryingprotein(no.
118)involved inpathogenesis[62].Takentogether,theOMV
subproteomic results appeared aligned with the functional
results pertinent to drug resistance, SOS, and cytotoxicity.
4. Discussion
Vesiculation from P. aeruginosa under ciproﬂoxacin treat-
mentwasinvestigatedwithmultipleapproaches.OMVswere
isolated from the wild-type strain in which SOS is induced
by ciproﬂoxacin and from the lexAN strain in which SOS
is repressed. Cell morphology after the treatment showed
cell ﬁlamentation, conﬁrming SOS, while OMVs were not
changed signiﬁcantly in size during SOS. Vesiculation as
determined chemically by the OMV protein and lipid levels
and functionally by cytotoxicity is stimulated by the drug
treatment, higher in the wild-type strain but suppressed in
the lexAN strain. The overall increases for the wild-type and
thelexAN strainssuggestthatthestimulationisattributedby
theSOS-relatedandtheindependentfactors;thesuppression
of further increase in the lexAN strain suggests that the
additional augmentation involves SOS. The cytotoxicity of
OMVs and the bacterial physiology under the antibiotic
treatment and SOS were reﬂected by the results of the OMV
subproteomic analysis.
An intriguing observation is the presence of cytosolic
proteins in OMVs. Considering the hydrophobic nature of
outer membrane, we were tempted to suspect contamination
of OMVs with the cytosolic proteins. Nevertheless, the
presence of the cytosolic proteins in OMVs is not just
coincidental but consistently documented [63]. In fact,
GroEL (no. 75), ribosomal proteins (nos. 76, 121, and 124),
and DNA binding proteins (no. 96, 115) were detected
in outer membrane [52, 64–66] and OMV fractions [52,
67]. The possible mechanisms for their OMV inclusion
may involve association of the cytoplasmic proteins with
membrane proteins that may bring the former to membrane
proximity.Forexample,peptidyl-prolylcis-transisomerase,a
membrane-associated protein (no. 95 in Table 2), is a trigger
factor that is highly conserved in most bacteria [68, 69].
The presence of the trigger factor in the stressed cells is
reasonable as the trigger factor is generally believed to playThe Scientiﬁc World Journal 15
a central role in bacterial survival of environmental insult.
Since the trigger factor in E. coli is associated with the 50S
ribosomal subunit [70]a n dG r o E L[ 71–73], the factor is
likely to be translocated with 50S ribosomal protein L28 and
GroEL to OMVs. Besides, because OMVs can package DNA
[48, 74]a n dP. aeruginosa OMVs carry DNA [75], the DNA
binding proteins, such as DNA-binding stress protein (no.
115) and DNA-methyltransferase (no. 96), may be delivered
into OMVs through hitching onto DNA.
The molecular mechanisms behind the vesiculation
stimulation during SOS remain poorly understood. OMVs
are generated from living cells by budding from outer
membrane bulges with subsequent ﬁssion [6, 7, 48, 74, 76].
Vesiculation does not concur with cell lysis, for OMVs
package newly synthesized proteins [77–79]. These may be
thereasonsthatOMVyieldsweretoolowwhenciproﬂoxacin
was used at and above MBC (data not shown), but the
OMV levels were high when the drug was administered
at 1μg/mL. Therefore, the increase in the OMV protein
levels observed in this work from the cultures treated with
ciproﬂoxacin at 1μg/mL is unlikely to result from cell lysis,
especially as lysed cells barely were observed in the culture
treated with the drug. The OMV protein levels are most
likely to reﬂect the vesiculation stimulation during SOS.
Indeed, the SOS-induced vesiculation is corroborated by
the OMV lipid quantiﬁcation. The OMV induction can
be interpreted by combination of cell division delay and
envelope alteration incurred in SOS. During SOS, sulA is
induced, whose product inhibits and delays cell division
transientlyuntilDNAdamageisameliorated.InE.coli,thisis
achieved by SulA binding to FtsZ to block septum formation
[42, 43, 80, 81]; similarly, a complex of P. aeruginosa SulA
with FtsZ has been reported [82]. Inhibition of cell division
was observed in P. aeruginosa treated with ciproﬂoxacin
(Figure 2). According to the model of OMV biogenesis
[28], such an episode of division inhibition may invoke
temporary impact on the envelope structure, stimulating
OMV generation.
Our ﬁnding of vesiculation stimulation during SOS is
highly signiﬁcant. On one hand, suppression of the SOS-
repair network by LexA in E. coli with engineered bacterio-
phage increased bactericidal eﬀects of SOS-inducing antibi-
otics in vitro and enhanced survival of infected mice in vivo
[83],pavingawayfortheLexA-basedtherapeuticstrategy.In
parallel are our results that LexA represses OMV stimulation
and cytotoxicity, yet the lexAN-based strategy fails to elim-
inate them (Figures 3 and 4), pointing to existence of LexA
independentmechanisms.TheOMVproteinlevelsincreased
in the cultures of the ciproﬂoxacin-treated lexAN mutant;
the noncleavable LexA even appeared to contribute to
productionofsomeOMVproteins(Figure 3(a)andTable3).
The observations lead to the SOS-independent mechanisms
that demand future endeavor in investigation. On the other
hand, SOS appears responsible for the antibiotic inducible-
bioﬁlm formation [30, 40] and vesiculation though the
mechanisms behind the induction seem a mystery. Our data
obtained with the OMV protein-, the lipid-, the cell- and the
proteomic-based approaches suggest that SOS plays a role in
theantibiotic-stimulatedvesiculationandinOMV-mediated
cytotoxicity to macrophage. The result may help develop
guidelines for antibiotic practice to prevent such side eﬀects
as vesiculation and the related cytotoxicity to host defense
cells.
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